Axa S.A. Bei Gene, Ltd. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Axa S.A. holds 53,513 shares of BGNE stock, worth $9.58 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

53,513

Previous 53,498 0.03%

Holding current value

$9.58 Million

Previous $7.63 Million 57.42%

% of portfolio

0.04%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$143.93 - $224.51 $2,158 - $3,367	15 Added 0.03%	53,513 $12 Million
Q2 2024 Aug 14, 2024	BUY	$129.52 - $174.32 $4,015 - $5,403	31 Added 0.06%	53,498 $7.63 Million
Q1 2024 May 15, 2024	SELL	$141.8 - $181.47 $236,380 - $302,510	-1,667 Reduced 3.02%	53,467 $8.36 Million
Q4 2023 Jul 16, 2024	BUY	$158.67 - $201.58 $264,502 - $336,033	1,667 Added 3.12%	55,134 $9.94 Million
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $204,842 - $260,239	-1,291 Reduced 2.29%	55,134 $9.94 Million
Q3 2023 Nov 14, 2023	SELL	$179.87 - $225.13 $34,714 - $43,450	-193 Reduced 0.34%	56,425 $10.1 Million
Q2 2023 Aug 14, 2023	BUY	$178.3 - $266.78 $6.44 Million - $9.64 Million	36,139 Added 176.47%	56,618 $10.1 Million
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $3.26 Million - $4.15 Million	15,120 Added 282.14%	20,479 $4.41 Million
Q4 2022 Feb 14, 2023	SELL	$125.51 - $229.3 $2.93 Million - $5.35 Million	-23,337 Reduced 81.32%	5,359 $1.18 Million
Q3 2022 Feb 14, 2023	BUY	$131.8 - $202.24 $24,119 - $37,009	183 Added 0.64%	28,696 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $24,119 - $37,009	183 Added 0.64%	28,696 $3.87 Million
Q2 2022 Feb 14, 2023	SELL	$121.11 - $216.05 $66,973 - $119,475	-553 Reduced 1.9%	28,513 $4.61 Million
Q2 2022 Aug 15, 2022	SELL	$121.11 - $216.05 $66,973 - $119,475	-553 Reduced 1.9%	28,513 $4.62 Million
Q1 2022 Feb 14, 2023	BUY	$146.52 - $269.56 $54,212 - $99,737	370 Added 1.29%	29,066 $5.48 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $43,662 - $80,328	298 Added 1.04%	29,066 $5.48 Million
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $85,504 - $133,932	344 Added 1.21%	28,768 $7.79 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $3.31 Million - $5.35 Million	-13,266 Reduced 31.82%	28,424 $10.3 Million
Q2 2021 Aug 13, 2021	SELL	$292.75 - $367.01 $1.46 Million - $1.82 Million	-4,972 Reduced 10.66%	41,690 $14.3 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $28,409 - $41,651	109 Added 0.23%	46,662 $16.2 Million
Q4 2020 Feb 12, 2021	BUY	$221.31 - $316.61 $3.53 Million - $5.05 Million	15,955 Added 52.14%	46,553 $12 Million
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $521,758 - $790,001	2,758 Added 9.91%	30,598 $8.76 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $160,078 - $252,469	1,292 Added 4.87%	27,840 $5.25 Million
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $249,406 - $354,519	-2,047 Reduced 7.16%	26,548 $3.27 Million
Q4 2019 Feb 18, 2020	BUY	$115.78 - $208.34 $83,130 - $149,588	718 Added 2.58%	28,595 $4.74 Million
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $4.92 Million - $6.05 Million	-40,769 Reduced 59.39%	27,877 $3.41 Million
Q2 2019 Aug 13, 2019	BUY	$113.99 - $146.86 $157,648 - $203,107	1,383 Added 2.06%	68,646 $8.51 Million
Q1 2019 May 14, 2019	BUY	$122.82 - $151.83 $8.26 Million - $10.2 Million	67,263 New	67,263 $8.88 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account